• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ascendis Pharma A/S - American Depositary Shares (NQ:ASND)

208.43 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Ascendis Pharma A/S - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 9 Next >
What Does the Market Think About Ascendis Pharma AS?
September 29, 2025
Ascendis Pharma AS's (NYSE: ASND) short interest as a percent of float has fallen 14.63% since its last report. According to exchange reported data, there are now 2.29 million shares sold short, which... 
Via Benzinga
$100 Invested In Ascendis Pharma 10 Years Ago Would Be Worth This Much Today
September 25, 2025
Ascendis Pharma (NASDAQ: ASND) has outperformed the market over the past 10 years by 13.64% on an annualized basis producing an average annual return of 26.77%. Currently, Ascendis Pharma has a market... 
Via Benzinga
PTC Therapeutics Could Challenge BioMarin For Metabolic Disorder Treatment
September 08, 2025
BioMarin's Palynziq significantly lowered blood phenylalanine in teens with PKU, with nearly half reaching target levels in the Phase 3 study. 
Via Benzinga
$100 Invested In Ascendis Pharma 10 Years Ago Would Be Worth This Much Today
September 08, 2025
 
Via Benzinga
Here's How Much $100 Invested In Ascendis Pharma 10 Years Ago Would Be Worth Today
September 04, 2025
 
Via Benzinga
How Do Investors Really Feel About Ascendis Pharma?
August 28, 2025
 
Via Benzinga
Earnings Scheduled For August 7, 2025
August 07, 2025
 
Via Benzinga
Peering Into Ascendis Pharma's Recent Short Interest
July 03, 2025
 
Via Benzinga
Is Ascendis Pharma Gaining or Losing Market Support?
June 03, 2025
 
Via Benzinga
ASCENDIS PHARMA A/S - ADR (NASDAQ:ASND) Combines Technical Strength and High-Growth Momentum
September 01, 2025
Ascendis Pharma (ASND) excels in both technical & fundamental momentum, meeting Minervini's Trend Template criteria for high-growth stocks poised for potential outperformance. 
Via Chartmill
If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today
August 19, 2025
 
Via Benzinga
Ascendis (ASND) Q2 2025 Earnings Call Transcript
August 07, 2025
Via The Motley Fool
Topics Earnings
What's Driving the Market Sentiment Around Ascendis Pharma?
August 06, 2025
 
Via Benzinga
What's Driving the Market Sentiment Around Ascendis Pharma?
August 04, 2025
 
Via Benzinga
$100 Invested In This Stock 10 Years Ago Would Be Worth This Much Today
July 28, 2025
 
Via Benzinga
If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today
May 29, 2025
 
Via Benzinga
Earnings Scheduled For May 1, 2025
May 01, 2025
 
Via Benzinga
A Glimpse of Ascendis Pharma's Earnings Potential
April 30, 2025
 
Via Benzinga
Here's How Much $1000 Invested In Ascendis Pharma 10 Years Ago Would Be Worth Today
July 22, 2025
 
Via Benzinga
$100 Invested In This Stock 10 Years Ago Would Be Worth This Much Today
July 07, 2025
 
Via Benzinga
$100 Invested In This Stock 10 Years Ago Would Be Worth This Much Today
June 12, 2025
 
Via Benzinga
If You Invested $100 In This Stock 10 Years Ago, You Would Have This Much Today
May 21, 2025
 
Via Benzinga
Here's How Much You Would Have Made Owning Ascendis Pharma Stock In The Last 15 Years
May 06, 2025
 
Via Benzinga
This Twilio Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Monday
May 05, 2025
 
Via Benzinga
Why ASCENDIS PHARMA A/S - ADR (NASDAQ:ASND) could fit Mark Minervini’s high-growth criteria
April 28, 2025
A fundamental and technical analysis of (NASDAQ:ASND): Is ASCENDIS PHARMA A/S - ADR (NASDAQ:ASND) suited for high growth investing? 
Via Chartmill
If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today
April 15, 2025
 
Via Benzinga
Does ASCENDIS PHARMA A/S - ADR (NASDAQ:ASND) show the characteristics of a Minervini super stock?
April 04, 2025
A fundamental and technical analysis of (NASDAQ:ASND): Why the high growth investor may take a look at ASCENDIS PHARMA A/S - ADR (NASDAQ:ASND). 
Via Chartmill
Looking Into Ascendis Pharma's Recent Short Interest
March 26, 2025
 
Via Benzinga
Here's How Much $100 Invested In Ascendis Pharma 15 Years Ago Would Be Worth Today
March 25, 2025
 
Via Benzinga
Is ASCENDIS PHARMA A/S - ADR (NASDAQ:ASND) a Minervini-style stock?
March 14, 2025
A fundamental and technical analysis of (NASDAQ:ASND): Why the high growth investor may take a look at ASCENDIS PHARMA A/S - ADR (NASDAQ:ASND). 
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9 Next >
Recent Quotes
View More
Symbol Price Change (%)
GOOG  244.64
+0.00 (0.00%)
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap